# Bioavailability of BIBR 1048 MS Single Doses With or Without Pantoprazole in Healthy Subjects

> **NCT02170805** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BIBR 1048 MS capsule formulation A
- **DRUG:** BIBR 1048 MS capsule formulation B
- **DRUG:** BIBR 1048 MS powder plus solution
- **DRUG:** Pantoprazole

## Key facts

- **NCT ID:** NCT02170805
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-04
- **Primary completion:** 2001-06
- **Final completion:** —
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2014-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02170805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02170805, "Bioavailability of BIBR 1048 MS Single Doses With or Without Pantoprazole in Healthy Subjects". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02170805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*